Pablo J. Cagnoni
2020
In 2020, Pablo J. Cagnoni earned a total compensation of $3.4M as Chief Executive Officer at Rubius Therapeutics, a 100% increase compared to previous year.
Compensation breakdown
| Bonus | $410,231 |
|---|---|
| Option Awards | $2,437,850 |
| Salary | $579,167 |
| Other | $16,621 |
| Total | $3,443,869 |
Cagnoni received $2.4M in option awards, accounting for 71% of the total pay in 2020.
Cagnoni also received $410.2K in bonus, $579.2K in salary and $16.6K in other compensation.
Rankings
In 2020, Pablo J. Cagnoni's compensation ranked 3,366th out of 13,090 executives tracked by ExecPay. In other words, Cagnoni earned more than 74.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,366 out of 13,090 | 74th |
Division Manufacturing | 1,311 out of 5,624 | 77th |
Major group Chemicals And Allied Products | 497 out of 2,257 | 78th |
Industry group Drugs | 431 out of 1,957 | 78th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 411 | 75th |
Source: SEC filing on March 30, 2021.
Cagnoni's colleagues
We found three more compensation records of executives who worked with Pablo J. Cagnoni at Rubius Therapeutics in 2020.